NCT01604590View on ClinicalTrials.gov

Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions
Glioblastoma
Interventions
RADIATION

Magnetic Resonance Imaging (MRI)

Magnetic Resonance Imaging (MRI) will be used to compare bevacizumab to the images of vessel and tumor structure.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT01604590 - Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter